drugset / Trial / NCT00004807

Summary

OBJECTIVES: I. Extend current knowledge of the phenotype and natural history of Rett syndrome (RS). II. Continue the search for a cytogenetic and/or DNA marker. III. Study the effects of cholinergic drugs based on preliminary evidence for reduced levels of brain acetylcholine, while continuing supportive care to modify seizures, respiratory abnormalities, and motor disturbances, and improve nutrition, behavior, and learning. IV. Identify targets for future therapeutic interventions, e.g., growth factors, to influence neurologic recovery.

Timeline

Start
1995-01
Primary completion
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown Oral
Subject Donepezil Small molecule Oral
Subject Topiramate Small molecule Oral

Indications